2024 Benchmark Report: Digital, Advanced Analytics & Artificial Intelligence in Medical Affairs

/in , , , , , , , , , , , , , , , /by

The Medical Affairs Professional Society (MAPS) is pleased to share our 2024 Digital, Advanced Analytics and Artificial Intelligence (AI) in Medical Affairs report. This report is based on findings from 32 leading organizations representing the Pharmaceutical, Biotech, and Medical and Diagnostic Device sectors, and reflects broad leadership thinking about the current and future states of Medical Affairs (MA) AI capability and challenges.

Survey design and analysis: Boston Consulting Group led the preparation, execution and analyses of the GenAI survey and moderated the Ambassador GenAI and Advanced Analytics workshop during the MAPS conference on March 24th, 2024.

Survey respondents: 34 representatives from 32 companies responded to our survey.

Participating companies: Thank you to participants from 3M, Abbott, AbbVie, Amgen, Astellas, AstraZeneca, Baxter, Bayer, bioMérieux, BioNTech, BMS, Eisai, Lilly, Gilead, Ipsen, Jazz Pharmaceuticals, Kyowa Kirin, Lundbeck, Mallinckrodt, Merck & Co, Mundipharma, Novartis, Otsuka, Regeneron, Sanofi, Sumitomo Pharma, Takeda, Teva, UCB, Varian, Vertex, and Viatris for your valuable feedback and insights.

The opinions expressed here are those of members of the MAPS Ambassador Alliance and do not necessarily represent the perspectives of their respective companies.

 

Access Options

Leveraging diverse data sources for more impactful insights analysis

/in , , , , , , , , , , , /by

Objectives:

Determining the most effective medical or commercial strategy requires measuring what’s happening in the market via a strong insights management process. Powering your insights process with different data sources (such as social media and other online conversations, medical information, congresses, advisory boards, and field observations) is critical for a full 360-degree view of the market.

In this discussion, you’ll learn:

  1. Strengths and weaknesses of different insight data sources from a business perspective
  2. How technologies like AI-supported analysis and reporting help you integrate data sources to deeply understand disease communities
  3. Real-world results pharma leaders are achieving by integrating data sources and applying AI-supported insights management processes

Access Options

Digital First Communications: How Digital Transformation is Opening Opportunities in Medical Affairs

/in , , , , , , , , , , , /by

This series of the Elevate Podcast illuminates the Inspiration and Impact, content Compliance & Approval, MSL utilization, Training & Evolution, the Technology Stack, and the Future of Modular Content.

Read more
Omnichannel Integration in Medical Affairs: From Aspiration to Reality

Omnichannel Integration in Medical Affairs: From Aspiration to Reality

/in , , , , , , , , , , , , /by

Omnichannel Integration in Medical Affairs: From Aspiration to Reality

Objectives:

Omnichannel communication holds the promise of reshaping interactions between the pharmaceutical industry and healthcare professionals (HCPs), revolutionizing engagement through personalized and seamless connections. Medical Affairs teams are in a unique position to engage with and provide HCPs with the information and education they seek, including in-depth clinical data, additional analyses and treatment updates. While Medical Affairs teams have the capacity to harness this transformative power, the pharmaceutical industry has been slow to fully embrace this revolution. Crafting effective omnichannel strategies remains a formidable challenge, laden with barriers.

Our webinar offers a platform for attendees to engage with a diverse group of Medical Affairs omnichannel experts, discover their distinctive perspectives, navigate common obstacles, and gain firsthand insights into pragmatic omnichannel integration solutions.

Key areas of focus will include:

·      Unpacking Omnichannel Strategies: Understanding the added value for customers and organizations, and the need to diverge from conventional single or multichannel approaches

·      Overcoming Barriers: Identifying and surmounting the obstacles hindering Medical Affairs teams' success with omnichannel, and exploring actionable solutions

·      Forging the Path to Omnichannel Success: Strategic drivers and actions, and how to institute them effectively across organizational landscapes.

Access Options

The Discoverability Dilemma: Navigating the Maze of Digital Content in Healthcare

/in , , , , , , , , , , , , , , , , , /by

The MAPS Puerto Rico Roundtable hosted by Real Chemistry in March 2024 discussed the integration of digital platforms, AI, and personalized content to enhance engagement with healthcare providers (HCPs). The panel emphasized the shift towards real-time, tailored information delivery and the importance of leveraging insights from both traditional and digital sources to support effective engagement strategies while ensuring compliance.

Read more
Camino Innovate Featured

Moving on from the maybes: Real-life uses of generative AI in Medical Affairs

/in , , , , , , , , , , /by

MAPS has been educating and sharing expertise on genAI since ChatGPT first exploded onto the scene in early 2023. This year, as the dust settles, we focus on sharing the learnings from a year of pilots and projects to help others begin or accelerate their journey.

Read more
How Machine Learning Can Be Used to Understand Audiences

How Machine Learning Can Be Used to Understand Audiences

/in , , , , , , , , , , , , /by

In this podcast, we explore machine learning as a way to get information about an audience.

Read more
Digital First Medical Affairs: GenAI: The Importance of Prompt Engineering

Digital First Medical Affairs: GenAI: The Importance of Prompt Engineering

/in , , , , , , , , , , , , /by

In this podcast, we dive into a really important area that can significantly influence your GenAI results – Prompt Engineering and other areas.

Read more
Generative AI: Use Cases, Their Impact, and What’s Next for Medical Affairs

Generative AI: Use Cases, Their Impact, and What’s Next for Medical Affairs

/in , , , , , , , , , , /by

Generative AI: Use Cases, Their Impact, and What’s Next for Medical Affairs

Objectives:

As the dust starts to settle around the hype with Generative AI, we believe that the opportunity is right before us to get truly “human-like” understanding at scale. Gen AI allows a unique ability to convert unstructured data into structured information, glean insights and then create a variety of medical content in a myriad of formats.

The webinar will showcase results from use of Generative AI in medical information, content generation and insights. It will also focus on stance taken by industry bodies Journals, Societies, ISMPP [International Society of Publications Professionals] and Regulators in releasing guidance to their members.

It will conclude by taking a crystal ball to look at how the future is unfolding with an ecosystem of models and technologies.

By the end of this webinar, attendees should have a better understanding of use-cases of Generative AI in Medical Affairs and will see results to help inform thinking and build a future roadmap.

Access Options

Utilizing Audience-Related Insights to Support Omnichannel Strategy in Medical Affairs

Utilizing Audience-Related Insights to Support Omnichannel Strategy in Medical Affairs

/in , , , , , , , , , , , , , /by

In this podcast, we delve into the world of omnichannel strategies in Medical Affairs, where understanding your audience’s educational needs and communication preferences is pivotal for delivering relevant and engaging data dissemination.

Read more

Connect with Us

602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073

© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.

Subscribe to MAPS event and resource updates
MAPS Program Support Services
Policies and Positions